Skip to main content
. 2022 May 16;9:864839. doi: 10.3389/fmolb.2022.864839

FIGURE 1.

FIGURE 1

Expression levels of miRNA-122, miRNA-483, and miRNA-335 in serum. (A) Serum expression of miRNA-122 in patients with HCC (n = 90) and HCV (n = 90) as compared to healthy people (n = 60). (B) Relative to healthy people (n = 60), the fold change in serum expression miRNA-483 in patients with HCC (n = 90) and HCV (n = 90). (C) Fold change in the serum expression miRNA-335 level in HCC (n = 90) and HCV (n = 90) patients compared to healthy persons (n = 60). Values are expressed as mean ± SEM (95% CI). (A) Significant difference from the control group at p < 0.05. (B) Significant difference from the HCV group at p < 0.05.